Webdunia - Bharat's app for daily news and videos

Install App

Irrfan Khan reveals his 'rare disease' as 'NeuroEndocrine Tumour’

Webdunia
Saturday, 17 March 2018 (11:59 IST)
International star Irrfan Khan, who has recently left his fans worried as he tweeted about his ‘rare disease’, on Friday revealed that he has been suffering from ‘Neuro Endocrine Tumour’.
On a Twitter post, Irrfan said, 'The unexpected makes us grow, which is what the past few days have been about. Learning that I have been diagnosed with NeuroEndocrine Tumour as of now has admittedly been difficult, but the love and support of those around me and that I found within me has brought me to a place of hope. The journey of this is taking me out of the country, and I request everyone to continue sending their wishes. As for the rumours that were floated NEURO is not always about the brain and googling is the easiest way to do research. To those who waited for my words, I hope to be back with more stories to tell.”
 
Irrfan's post last week disclosing that he has been suffering from a ‘rare disease’ had left the whole of Bollywood and his fans in utter shock but the actor, had promised to share more information after a ‘conclusive diagnosis’.
 
Earlier, his wife Sutapa Sikdar also issued a statement about her husband’s health, requesting people to not spread rumours about her husband’s health.
 
In the statement posted on her Facebook account, she thanked Irrfan’s fans for their good wishes and their concern but also urged them to stop speculating about the disease Irrfan is suffering from. (UNI)
 

Related Article

See All

Top News

IND vs AUS, Perth Test: Yashasvi Jaiswal, KL Rahul extend Sunil Gavaskar legacy in Australia

Jailed Umar Khalid tests India's anti-terror law

WI vs BAN, 1st Test: West Indies eye 400 after strong opening day against Bangladesh

Must Read

Landslides and mudslides: Can they be prevented?

Fungi are adapting to body heat — a 'doomsday scenario'

Could a Syrian war criminal be attending Paris Olympics?

Next Article
Show comments